Jagsonpal Pharmaceuticals Shareholding

Jagsonpal Pharmaceuticals Ltd Shareholding Pattern

The Jagsonpal Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Jagsonpal Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Jagsonpal Pharmaceuticals Ltd (NSE: JAGSNPHARM, BSE: 507789) operates in the Health technology sector and Pharmaceuticals: generic industry. Monitoring the Jagsonpal Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Jagsonpal Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Jagsonpal Pharmaceuticals Ltd shareholding for Dec 2025 is:

• Promoters: 67.39%
• FII: 2.12%
• DII: 0.15%
• Public: 30.34%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Jagsonpal Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Jagsonpal Pharmaceuticals Ltd.

• Dec 2025: 67.39%
• Sept 2025: 67.54%
• Jun 2025: 67.65%
• Mar 2025: 67.78%
• Dec 2024: 67.81%

Promoter stake remains largely stable, showing consistent ownership structure.

Jagsonpal Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Jagsonpal Pharmaceuticals Ltd.

• Dec 2025: 2.12%
• Sept 2025: 2.12%
• Jun 2025: 2.18%
• Mar 2025: 2.10%
• Dec 2024: 2.10%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Jagsonpal Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0.15%
• Sept 2025: 0.09%
• Jun 2025: 0.05%
• Mar 2025: 0.00%
• Dec 2024: 0.00%

DII stake in Jagsonpal Pharmaceuticals Ltd has increased over time, indicating growing domestic institutional confidence.

Jagsonpal Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 30.34%
• Sept 2025: 30.25%
• Jun 2025: 30.12%
• Mar 2025: 30.11%
• Dec 2024: 30.08%

Public participation in Jagsonpal Pharmaceuticals Ltd has increased, indicating rising retail investor interest.

Jagsonpal Pharmaceuticals Ltd Government Holding

Government holding in Jagsonpal Pharmaceuticals Ltd currently stands at 0%.

Jagsonpal Pharmaceuticals Ltd operates without significant government ownership.

Jagsonpal Pharmaceuticals Ltd Shareholding Analysis Summary

The Jagsonpal Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Jagsonpal Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Jagsonpal Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.